The latest articles from BioStock
» Taking control of our genes to treat diseases
» New contract partner and millions in revenue for Iconovo
» Follow BioStock Live STHLM live broadcast
» Immunicum's research director presented at cancer seminar with Nobel glory
» Saniona: Royalty income in sight – strengthens portfolio within eating disorders
Read BioStock's latest newsletter for week 11 here
Hansa Biopharma has selected a drug candidate for clinical development from NiceRprogram (Novel IgG Cleaving Enzymes for Repeat Dosing). Read more.
BioInvent International announces broad anti-TNFR2 program for the treatment of solid tumors. Read moreThe company also invites you to investor evenings in Stockholm, Malmö and Gothenburg. Read more.
Bristol Myers Squibb and Pfizer presents positive results from the phase IV study AUGUST where eliquis compared to warfarin in patients with non-valvular atrial fibrillation who have recently experienced acute coronary syndrome and/or are undergoing percutaneous coronary intervention. Read more.
ADDvise Groups subsidiary LabRoom has received an order from a diagnostics company headquartered in Geneva, worth SEK 2,5 million. The order concerns laboratory equipment for a sample collection lab. Read more.
The new board begins its review of the situation in Oasmia Pharmaceutical. Read more.
Bavarian Nordic publishes information about the allocation of call options to management. Read more.
Eurocine Vaccines presentation on Stock Market Day Stockholm is now available online. Read more.
Notices of meetings:
Elos Medtech Oncology Venture
Reports/Communiqués:
Biovica (communique) Biovica (report) Ortivus Orexo Bavarian Nordic Oncology Venture SynAct Pharma
News received yesterday:
FDA has accepted RhoVacs application for a pre-IND meeting, which will address the clinical development program with the drug candidate RV001. Read more.
Eurocine Vaccines published its information memorandum regarding the rights issue with a subscription period of March 25 – April 8. Read more.
Affibody has signed an agreement with Alexion Pharmaceuticals about developing ABY-039Affibody will receive a $25 million upfront payment. Read more.
In a new article published in Nature Communications. was used Attanas technology to develop an antibody for matching donor and patient in transplants. Read more.
LifeAssays has signed a distribution agreement with Accelerated Equine Health who has worked on the launch of LifeAssay's test for horses SAA in the USA under a so-called Letter of Intent. Read moreThe company also published a correction regarding days of the week included in a previous press release. Read more.
Zealand Pharma has entered into a collaboration with Alexion Pharmaceuticals on new peptide therapies for diseases related to the immune system, which means that Zealand Pharma will receive a USD 25 million advance payment. Read moreThe company has also increased its share capital as a result of Alexion purchasing shares in Zealand. Read more.
Pillox, which uses an app connected to a smart medication dispenser to help patients take their medication on time, has started a collaboration with the Scandinavian part of BayerThe collaboration touches on many areas with the aim of expanding the market, introducing more people to the smart digital pillbox, and demonstrating that Pilloxa reduces the societal costs of non-adherence. Read more.
Novo Nordisk has applied for FDA-approval for oral semaglutide and Ozempic. Read more.
SenzaGen announces that warrants have been exercised and that shares have been allocated. Read more.
BioInvent Internationals The extraordinary general meeting has decided on a new share issue and a rights issue that together could provide the company with SEK 280 million before issue costs. Read more.
MSD announced that the European Commission has approved Keytruda as a combination treatment for more people with lung cancer. Read more.
AroCell has received a new patent granted by European Patent OfficeThe patent refers to AroCell's proprietary technology for the specific and sensitive immunological measurement of thymidine kinase 1 (TK1) in serum. Read more.
Rocks Home Libra is now approved within EU for the treatment of people with hemophilia A (congenital factor VIII deficiency) without inhibitors. Read more.
Recipharm has awarded the 2018 International Environmental Award to Dr Bryan Brooks, professor of environmental science and biomedicine at Baylor University in Waco, Texas. Read more.
MediaRights has won a tender for personal alarms in the city of Solna together with Stanley Security. Read more.
MedCaps subsidiary Abilia has signed an agreement to acquire all shares in Comei, a Swedish company with established products in cognitive aids. Read more.
Winners in the lunch trade: Initiator Pharma +7,69%, Spago +6,45%, Eurocine Vaccines +5,29%, Cereno Scientific +4,75%, Enzymatica +4,55%, Alligator Bioscience +4,38%
Losers in the lunch trade: Klaria -5,74%, Prebona -5,01%, Alteco -4,96%, Cline Scientific -4,70%, MedicPen – 4,42%, RLS Global -4,36%
Index: OMXS30 +0,14%, Healthcare +0,20%
More articles from BioStock
» 2cureX expands operations to prevent cancer
» Cereno Scientific adds another top international name to its Scientific Advisory Board
» Karolinska Development's portfolio company Promimic enters into partnership with Onkos Surgical
» Acting FDA Commissioner Appointed
» BioStock visited Sedermeradagen in Copenhagen
[et_bloom_inline optin_id=”optin_4″]
BioInvent International announces broad anti-TNFR2 program for the treatment of solid tumors. Read moreThe company also invites you to investor evenings in Stockholm, Malmö and Gothenburg. Read more.
Bristol Myers Squibb and Pfizer presents positive results from the phase IV study AUGUST where eliquis compared to warfarin in patients with non-valvular atrial fibrillation who have recently experienced acute coronary syndrome and/or are undergoing percutaneous coronary intervention. Read more.
ADDvise Groups subsidiary LabRoom has received an order from a diagnostics company headquartered in Geneva, worth SEK 2,5 million. The order concerns laboratory equipment for a sample collection lab. Read more.
The new board begins its review of the situation in Oasmia Pharmaceutical. Read more.
Bavarian Nordic publishes information about the allocation of call options to management. Read more.
Eurocine Vaccines presentation on Stock Market Day Stockholm is now available online. Read more.
Notices of meetings:
Elos Medtech Oncology Venture
Reports/Communiqués:
Biovica (communique) Biovica (report) Ortivus Orexo Bavarian Nordic Oncology Venture SynAct Pharma
News received yesterday:
FDA has accepted RhoVacs application for a pre-IND meeting, which will address the clinical development program with the drug candidate RV001. Read more.
Eurocine Vaccines published its information memorandum regarding the rights issue with a subscription period of March 25 – April 8. Read more.
Affibody has signed an agreement with Alexion Pharmaceuticals about developing ABY-039Affibody will receive a $25 million upfront payment. Read more.
In a new article published in Nature Communications. was used Attanas technology to develop an antibody for matching donor and patient in transplants. Read more.
LifeAssays has signed a distribution agreement with Accelerated Equine Health who has worked on the launch of LifeAssay's test for horses SAA in the USA under a so-called Letter of Intent. Read moreThe company also published a correction regarding days of the week included in a previous press release. Read more.
Zealand Pharma has entered into a collaboration with Alexion Pharmaceuticals on new peptide therapies for diseases related to the immune system, which means that Zealand Pharma will receive a USD 25 million advance payment. Read moreThe company has also increased its share capital as a result of Alexion purchasing shares in Zealand. Read more.
Pillox, which uses an app connected to a smart medication dispenser to help patients take their medication on time, has started a collaboration with the Scandinavian part of BayerThe collaboration touches on many areas with the aim of expanding the market, introducing more people to the smart digital pillbox, and demonstrating that Pilloxa reduces the societal costs of non-adherence. Read more.
Novo Nordisk has applied for FDA-approval for oral semaglutide and Ozempic. Read more.
SenzaGen announces that warrants have been exercised and that shares have been allocated. Read more.
BioInvent Internationals The extraordinary general meeting has decided on a new share issue and a rights issue that together could provide the company with SEK 280 million before issue costs. Read more.
MSD announced that the European Commission has approved Keytruda as a combination treatment for more people with lung cancer. Read more.
AroCell has received a new patent granted by European Patent OfficeThe patent refers to AroCell's proprietary technology for the specific and sensitive immunological measurement of thymidine kinase 1 (TK1) in serum. Read more.
Rocks Home Libra is now approved within EU for the treatment of people with hemophilia A (congenital factor VIII deficiency) without inhibitors. Read more.
Recipharm has awarded the 2018 International Environmental Award to Dr Bryan Brooks, professor of environmental science and biomedicine at Baylor University in Waco, Texas. Read more.
MediaRights has won a tender for personal alarms in the city of Solna together with Stanley Security. Read more.
MedCaps subsidiary Abilia has signed an agreement to acquire all shares in Comei, a Swedish company with established products in cognitive aids. Read more.
Winners in the lunch trade: Initiator Pharma +7,69%, Spago +6,45%, Eurocine Vaccines +5,29%, Cereno Scientific +4,75%, Enzymatica +4,55%, Alligator Bioscience +4,38%
Losers in the lunch trade: Klaria -5,74%, Prebona -5,01%, Alteco -4,96%, Cline Scientific -4,70%, MedicPen – 4,42%, RLS Global -4,36%
Index: OMXS30 +0,14%, Healthcare +0,20%
More articles from BioStock
» 2cureX expands operations to prevent cancer
» Cereno Scientific adds another top international name to its Scientific Advisory Board
» Karolinska Development's portfolio company Promimic enters into partnership with Onkos Surgical
» Acting FDA Commissioner Appointed
» BioStock visited Sedermeradagen in Copenhagen
[et_bloom_inline optin_id=”optin_4″]